Alfonso de Hoyos Fernández de Córdova is affiliated with the Higher Polytechnic School at Antonio de Nebrija University , specializing in Transport Engineering and Infrastructure within the GREEN Research Group on Automotive Engineering . He holds dual PhDs: one in Neuroscience (2011, Complutense University of Madrid) for work on Synchronization and coherence in brain activity , and another in Automotive Engineering (2025, Universidad Antonio de Nebrija) for research on Non-invasive methodology for vehicle suspension parameter identification . Education: PhD in Neuroscience, Complutense University of Madrid (2011) PhD in Automotive Engineering, Universidad Antonio de Nebrija (2025) His research spans Transport Engineering , Automotive Systems , Cardiology , and Biomedical Imaging , focusing on hemodynamic assessment of coronary circulation , non-destructive testing of magnetic materials , computational fluid dynamics , and magnetoencephalography . He has pioneered methodologies for intracoronary pressure and flow velocity analysis and microvascular conductance evaluation , integrating CFD simulations with clinical diagnostics to improve cardiovascular interventions. Email: ahoyos@nebrija.es
Sara Tehrani is a clinical researcher at Karolinska Institutet's Department of Clinical Sciences, Danderyd Hospital, specializing in microvascular dysfunction across acute and chronic conditions. As an Affiliated Researcher and Associate Consultant in Internal Medicine, she leads investigations into sepsis, diabetes, and cardiovascular disease with focus on developing innovative bedside assessment methods for microcirculation. Her primary research interests center on microvascular regulation and dysfunction, particularly in sepsis and diabetes. She investigates how impaired small vessel function contributes to disease progression and develops point-of-care devices for bedside microcirculation assessment. Her work spans three major clinical studies: MIND (Microangiopathy in Diabetes with 300 patients and 100 controls), SCAPIS spectrum (900 subjects with cardiovascular risk), and CapriS (60 sepsis patients and 30 controls). Analysis of her recent publications reveals a strong focus on microvascular assessment techniques, sepsis-related cardiac dysfunction, and vascular complications of tobacco products. Her research increasingly integrates cardiovascular biomarkers with microcirculatory measurements to improve risk prediction in critical illness. Dr. Tehrani actively supervises doctoral candidates and teaches medical students at Karolinska Institutet. Her current research is supported by multiple grants from Region Stockholm and the Swedish Society of Medicine through 2026, focusing on developing innovative methods for assessing microvascular function in clinical practice. She leads the Clinical Research Laboratory at Danderyd Hospital and serves as Head of Research, Education & Development for the Department of Medical Specialties. Her team includes PhD students and researchers working collaboratively on microcirculation assessment and vascular dysfunction across various clinical conditions.
Dr. Wendy Goodwin is a Clinical Associate Professor at the University of Queensland 's Faculty of Science , specializing in Veterinary Anaesthesia and Analgesia . She is an affiliate of the Centre for Innovation in Pain and Health Research (CIPHeR) and a Fellow of the Australian and New Zealand College of Veterinary Scientists in Veterinary Anaesthesia and Critical Care . Veterinary degree (2004) and PhD (2013) from University of Queensland Specialist in veterinary anaesthesia (2008), anaesthesia and critical care (2013) Her research focuses on veterinary anaesthesia , microcirculatory responses , and patient safety in veterinary practices. Current projects include 4% alfaxalone pharmacokinetics in dogs , veterinary safety culture , and snake envenomation management . She has published extensively in journals like Veterinary Anaesthesia and Analgesia and Australian Veterinary Journal . Recent collaborative studies demonstrate her expertise in equine anaesthesia (alfaxalone research), feline cardiovascular diagnostics , and cross-species microcirculation analysis. Her work bridges veterinary clinical practice with human healthcare insights , particularly in second victim support structures and humble leadership impacts. Recipient of 2008 Membership in Equine Medicine 2013 Membership in Veterinary Anaesthesia 2016 Fellowship in Veterinary Anaesthesia As Principal Advisor for multiple Doctor of Veterinary Clinical Science candidates, she supervises research in traumatic haemorrhagic shock , equine anaesthesia safety , and novel injectable sedatives . Her 2018-2020 grants from the John & Mary Kibble Trust supported tissue oxygen saturation studies in horses.
Martin Iversen Hagve is an Associate Professor at the Department of Clinical Medicine , UiT The Arctic University of Norway, with research expertise in metabolic responses to surgical trauma, insulin resistance, and mitochondrial physiology. His work bridges critical care nutrition with advanced physiological modeling in large animals. Key Research Areas : Surgery-Induced Insulin Resistance Mitochondrial Oxidative Stress Nutritional Interventions in Critical Care Cardioprotection Mechanisms Exercise Metabolism His recent publications (2020-2025) emphasize interorgan energy fluxes in sepsis models, perioperative carbohydrate strategies , and mitochondrial adaptations in surgical stress. Collaborative work spans diabetes technology , cardiovascular disease , and clinical practice guidelines .
Floor Harms is a Researcher in Anesthesiology at Erasmus University Medical Center, focusing on mitochondrial oxygenation, acute kidney injury, and hemodynamic monitoring in surgical contexts. Her work combines clinical research with advanced analytics to improve perioperative outcomes. Key investigations include predictive models for renal injury in cardiac surgery and AI-driven mitochondrial oxygen consumption analysis. Recent studies utilize porcine inflammation models and dynamic light scattering to assess microcirculatory changes. Her publications address anesthesia protocols, including liposomal bupivacaine applications for postoperative pain management.
Dr. Karin Rådholm is Senior Associate Professor at Linköping University's Department of Health, Medicine and Caring Sciences, with affiliations to the Faculty of Medicine and Health Sciences and Division of Prevention, Rehabilitation and Community Medicine. Her research focuses on type 2 diabetes prevention, metabolic disease management, and cardiovascular complications. She coordinates the DIATEST HELP trial investigating digital interventions for diabetes treatment and diet optimization, supported by grants from the Swedish Research Council and Diabetes Association. Research interests include: Cardiovascular risk factors in diabetes Microvascular health and atherosclerosis Health behavior interventions Geriatric diabetes management Her work employs epidemiological methods and clinical trials to address diabetes-related complications. Recent publications examine cardiovascular health metrics, microcirculatory impairments in dysglycemia, and geriatric hypertension. Key themes include early biomarkers for vascular complications, lifestyle interventions, and longitudinal health outcomes in aging populations. Honors include honorary research fellowships at The George Institute for Global Health (Sydney) and multiple research grants. She serves on boards for the Swedish Association for Hypertension, Stroke and Vascular Medicine and the National Research School in General Practice. Professional networks include Swedish Primary Care Diabetes (SPACE).
Shawn Bearden is a Professor of Exercise Physiology at Idaho State University. His research focuses on human endurance physiology, ultra-endurance performance, and microcirculatory dynamics in skeletal and cerebral vasculature. He holds a Ph.D. in Exercise Physiology from Florida State University and completed postdoctoral training at Yale School of Medicine, studying neurovascular interactions. Dr. Bearden collaborates with the U.S. Army on warfighter performance optimization and investigates mountain ultra-marathon runners. His work bridges scientific research with public understanding through a science-focused podcast. He teaches courses in biological imaging, anatomy & physiology, and comparative exercise physiology. His lab, located in Life Sciences 443, explores topics like blood-brain barrier permeability, thermoregulatory mechanisms, and vascular aging. Key research themes include the physiological limits of ultra-endurance athletes and the role of pericytes in vascular regeneration. Education: Ph.D. in Exercise Physiology, Florida State University (2000) M.S. in Exercise Science & Health Promotion, George Mason University (1996) B.S. in Education & Sports Medicine, University of Virginia (1994) Postdoctoral Fellow in Cellular & Molecular Neurobiology, Yale University School of Medicine (2001–2004) Research emphasizes the interplay between exercise, vascular health, and cognitive function. His studies on hyperhomocysteinemia’s effects on blood-brain barrier integrity and the role of pericytes in spinal cord injury recovery are particularly notable. Recent work explores pacing strategies in ultramarathons and environmental physiology adaptations. Teaching responsibilities include courses for pharmacy and physician assistant programs, emphasizing anatomy and imaging techniques. Grant activities include military-funded research on warfighter performance optimization and National Institutes of Health grants investigating vascular aging. Advising involves mentoring 1–3 graduate and undergraduate students annually through independent study modules. He actively publishes in high-impact journals like PLOS One , Blood , and Journal of Applied Physiology . Labs/Teams: His lab integrates advanced imaging and physiological testing to study microvascular networks. Collaborations include interdisciplinary teams at the John B. Pierce Laboratory and military research institutions.
Andreas M. Beyer, PhD, is a Professor in the Departments of Medicine and Physiology at the Medical College of Wisconsin (MCW) and co-director of the Basic and translational research program in Cardio-Oncology. His research focuses on mitochondrial dysfunction, telomerase biology, and microvascular pathophysiology in cardiovascular diseases and cancer therapy-induced toxicity. Education: PhD in Physiology from the University of Iowa (2007). Postdoctoral training at the University of Iowa and MCW. Appointments include roles as Research Program Director for Cardiothoracic Surgery and organizer of the Cardiovascular Center Seminar Series. He is a Fellow of the American Heart Association (FAHA). Research Interests include: mitochondrial redox signaling, non-canonical roles of telomerase in vascular health, cardio-oncology (cancer therapy-induced cardiovascular toxicity), and mechanisms of endothelial dysfunction in aging and disease. Key projects explore telomerase's mitochondrial protective functions, mitochondrial dynamics in coronary artery disease, and translational approaches to mitigate chemotherapy-induced vascular damage. Publications: Over 80 peer-reviewed articles in journals like Circulation Research, Hypertension, and PNAS. Recent work highlights endothelial TERT's role in coronary artery disease and the clinical implications of post-COVID-19 endothelial dysfunction. Awards: 2014 Microcirculatory Society Outstanding Young Investigator Award, 2016 FAHA designation. Active roles in editorial boards (e.g., Reactive Oxygen Species Journal) and professional societies (American Physiological Society). Labs/Teams: Leads the Andreas Beyer Lab at MCW, mentoring graduate students and postdocs in cardio-oncology and vascular biology. Collaborates on translational projects linking basic research to clinical diagnostics and therapies.
Jolanta Neubauer-Geryk is an Assistant Professor at the Center of Medical Simulations, Faculty of Medicine, Medical University of Gdańsk. She holds a Dr. Habil. degree and has been affiliated with the institution since 2014. Her professional background includes extensive research activities in clinical physiology, diabetes, and cardiovascular medicine. Her education includes a Doctorate (PhD) in 2001 and habilitation. Her research focuses on type 1 diabetes complications, cardiovascular risk factors, and microcirculatory dysfunction. Key interests include skin microangiopathy, immune profile analysis, and the application of Doppler imaging and L-arginine infusion tests for diagnostic purposes. Dr. Neubauer-Geryk has published 82 articles, with a focus on understanding vascular and metabolic pathways in diabetes. Her work spans pediatric populations and explores gender-specific differences, metabolic memory effects, and the role of biomarkers like P-Selectin and Angiogenin in disease progression. While no specific awards are listed, she has achieved 2 notable achievements in her career. Her grants and advising activities include one promoted thesis, though no advisees are named. She contributes to interdisciplinary teams within the Center of Medical Simulations, focusing on advanced diagnostics and clinical physiology applications. Her lab activities involve the development of novel techniques for assessing microcirculation, including Doppler-based methods and non-invasive oxygenation monitoring. These tools are applied to study diabetes-related vascular changes in both adults and children.
William Fearon, MD is a Professor of Medicine (Cardiovascular Medicine) and Chief of the Interventional Cardiology Section at Stanford University School of Medicine, as well as Chief of Cardiology at the VA Palo Alto Health Care System. He graduated from Dartmouth College and earned his MD from Columbia University. His research focuses on coronary physiology, including the FAME trials and development of the Index of Microcirculatory Resistance (IMR). He leads major clinical trials in interventional cardiology and heart transplantation, with over 350 publications. Awards include Fellowship in the American College of Cardiology and election to the American Society for Clinical Investigation. Education: B.A. in English, Dartmouth College (1990) M.D., Columbia University College of Physicians and Surgeons (1994) Residency: Stanford University Internal Medicine (1995-1998) Fellowships: Stanford General Cardiology & Interventional Cardiology (2002) Research Interests: Coronary physiology, FFR-guided interventions, cardiac allograft vasculopathy, transcatheter valve therapy. Current NIH funding supports studies on post-transplant vasculopathy. Active in editorial roles for Circulation: Cardiovascular Interventions and JACC journals. Key Trials: FAME 3 (5-year outcomes of PCI vs CABG) Contrast FFR validation (not recruiting) PASCAL valve repair trial (recruiting) Awards: Over 30 teaching awards from Stanford, named Master Fellow by Society of Cardiovascular Angiography. Labs: Leads a translational research lab investigating microvascular dysfunction and novel interventional therapies.
Dr. Esak (Isaac) Lee is an Assistant Professor at the Meinig School of Biomedical Engineering at Cornell University since 2019. He combines principles from engineering, biology, and medicine to develop novel approaches for improving human health, focusing on lymphatic and blood vessel biology. Current: Assistant Professor, Biomedical Engineering, Cornell University Previous: Postdoctoral Fellow, Wyss Institute & Boston University Education: Ph.D. in Bioengineering, Johns Hopkins University His research interests include: Microfluidics and organ-on-chip technology Tissue engineering and biomaterials Biomechanics and mechanobiology in vascular systems Molecular and cellular engineering for disease modeling Regenerative medicine applications for cancer and immune diseases Edema and lymphedema treatment strategies Dr. Lee's work emphasizes creating 3D organ-on-chip systems to study vascular interactions. His publications demonstrate expertise in lymphatic biology, cancer metastasis, and neurovascular modeling. Awarded: NSF Career Award (2024) Nancy and Peter Meinig Investigatorship (2019) Microcirculatory Society Lymphatic Research Award (2021) GRC Lymphatics Young Investigator Award (2018) BMES Cellular & Molecular Bioengineering Young Innovator (2023) As an educator, Dr. Lee teaches core topics in biomedical engineering including cancer immuno-engineering and biomaterials. His lab at Cornell fosters interdisciplinary research through bioengineered in vitro models that replicate human physiology with high precision.
Susana Cavallero is an Assistant Professor at the Charles R. Drew University of Medicine and Science, Department of Health & Life Sciences. Her research bridges vascular biology, cardiovascular development, and cardiometabolic disease with a focus on exercise physiology and animal models. She has received numerous accolades including the 2024 JEDI Award and Scientist Development Grants from the American Heart Association. University of Buenos Aires, Argentina: BS-MS in Biochemistry (2001), PhD in Cardiovascular Pathophysiology (2007), PharmD (2008) Research interests center on vascular mechanotransduction, SARS-CoV-2 inflammation, metabolic disease imaging, and cardiovascular development using zebrafish and mammalian models. Her 15 most recent publications span mechanistic studies on SCD1-catalyzed vascular protection, AI-driven plaque detection, and SARS-CoV-2 microthrombosis inhibition. Scientific awards include: CONICET Predoctoral Fellowship UBA Research Grant American Heart Association Fellowships Wright Foundation Award First Place Poster, UCLA Cardiovascular Symposium JEDI Award She has secured significant research funding including the Scientist Development Grant from AHA and participated in NAVBO training programs. While no direct student mentorship is listed, her work involves collaborative research with teams at UCLA and USC.
Dr. Daniel Gruneberg is a Physician in Training and Research Associate in the Department of Anesthesiology at Heidelberg University Hospital (UKHD). He is affiliated with the Group Hemostaseology, Hemodynamics and Septic Immunomodulation. His research focuses on coagulation disorders, hemorrhagic shock management, microcirculatory oxygenation, and clinical applications in anesthesiology and critical care. His work spans experimental studies using porcine models, biomarker analysis in surgical outcomes, and evaluation of diagnostic technologies like viscoelastic testing and hyperspectral imaging. Recent projects include investigating fibrinolytic potential in postpartum hemorrhage, crystalloid vs. catecholamine therapies for hemorrhagic shock, and non-invasive ventilation strategies for respiratory emergencies. No scientific awards or formal student advisees are listed. His contributions emphasize translational research bridging basic science with clinical practice in anesthesia and emergency medicine.
David C. Zawieja is a Regents Professor and Executive Director of the Cardiovascular Research Institute at Texas A&M University’s School of Medicine. He holds a PhD in Physiology from the Medical College of Wisconsin (1986) and a BS in Biology/Chemistry/Population Dynamics from the University of Wisconsin-Green Bay (1978). His research focuses on microcirculatory fluid and macromolecular transport, with emphasis on lymphatic system function. Key areas include lymph flow regulation, calcium-dependent contractile mechanisms, shear stress effects, and lymphangiogenesis. Techniques employed include intravital microscopy, fluorescent imaging, and mathematical modeling. Notable awards include the Imperial College London’s Distinguished Visiting Professorship and the Texas A&M System’s Regents Professor Award. His lab members include Student Research Assistant Seth Greiner and Assistant Research Scientist Wei Wang, PhD. The lab is affiliated with Texas A&M’s Cardiovascular Research Institute.
Dr. Richard Klabunde is a Professor of Physiology at Marian University College of Osteopathic Medicine since 2012. With over four decades of academic experience, he has held faculty positions at Ohio University Heritage College of Osteopathic Medicine, University of Illinois College of Medicine, and West Virginia University College of Medicine. He also served as a Senior Cardiovascular Group Leader at Abbott Laboratories and Director at the Deborah Research Institute. B.S. in Biology (Pepperdine University, 1970) Ph.D. in Physiology (University of Arizona College of Medicine, 1975) His research spans three major phases: (1) Skeletal muscle microcirculation regulation (1970-1985), (2) Cardiovascular drug mechanisms in heart failure/sepsis models (1985-2005), and (3) Diabetes/obesity impacts on coronary control systems. He pioneered isolated Langendorff heart models to study nitric oxide pathways and thrombolytic agents. Notable achievements include creating the educational websites www.cvphysiology.com and www.cvpharmacology.com , authoring two key textbooks, and receiving the American Physiological Society's highest teaching award. His scholarly work now focuses on medical education innovation, having transitioned from laboratory research to content development and consulting. Arthur C. Guyton Physiology Educator of the Year Award (2012) Dr. Klabunde's publications reflect his dual expertise in cardiovascular research and education, with recent works emphasizing thermal physiology modeling and 21st-century teaching methodologies.
